Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Chi Young Shim; Jiwon Seo; Iksung Cho; Chan Joo Lee; In Jeong Cho; Purevjargal Lhagvasuren; Seok Min Kang; Jong Won Ha; Gyoonhee Han; Yangsoo Jang; Geu Ru Hong

doi:10.1161/CIRCULATIONAHA.120.051992

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Chi Young Shim
, Jiwon Seo
, Iksung Cho
, Chan Joo Lee
, In Jeong Cho
, Purevjargal Lhagvasuren
, Seok Min Kang
, Jong Won Ha
, Gyoonhee Han
, Yangsoo Jang
, Geu Ru Hong

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	510-512
Number of pages	3
Journal	Circulation
Volume	143
Issue number	5
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.120.051992
Publication status	Published - 2021 Feb 2

Bibliographical note

Funding Information:
The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.120.051992

Cite this

Shim, C. Y., Seo, J., Cho, I., Lee, C. J., Cho, I. J., Lhagvasuren, P., Kang, S. M., Ha, J. W., Han, G., Jang, Y., & Hong, G. R. (2021). Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial. Circulation, 143(5), 510-512. https://doi.org/10.1161/CIRCULATIONAHA.120.051992

@article{bedc8f71cde2492b8de77298612bd52a,

title = "Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial",

keywords = "diabetes mellitus, diastole, echocardiography, stress, function, sodium-glucose transporter 2 inhibitors",

author = "Shim, \{Chi Young\} and Jiwon Seo and Iksung Cho and Lee, \{Chan Joo\} and Cho, \{In Jeong\} and Purevjargal Lhagvasuren and Kang, \{Seok Min\} and Ha, \{Jong Won\} and Gyoonhee Han and Yangsoo Jang and Hong, \{Geu Ru\}",

note = "Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).",

year = "2021",

month = feb,

day = "2",

doi = "10.1161/CIRCULATIONAHA.120.051992",

language = "English",

volume = "143",

pages = "510--512",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

Shim, CY, Seo, J, Cho, I, Lee, CJ, Cho, IJ, Lhagvasuren, P, Kang, SM, Ha, JW, Han, G, Jang, Y & Hong, GR 2021, 'Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial', Circulation, vol. 143, no. 5, pp. 510-512. https://doi.org/10.1161/CIRCULATIONAHA.120.051992

TY - JOUR

T1 - Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus

T2 - The IDDIA Trial

AU - Shim, Chi Young

AU - Seo, Jiwon

AU - Cho, Iksung

AU - Lee, Chan Joo

AU - Cho, In Jeong

AU - Lhagvasuren, Purevjargal

AU - Kang, Seok Min

AU - Ha, Jong Won

AU - Han, Gyoonhee

AU - Jang, Yangsoo

AU - Hong, Geu Ru

N1 - Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).

PY - 2021/2/2

Y1 - 2021/2/2

KW - diabetes mellitus

KW - diastole

KW - echocardiography, stress

KW - function

KW - sodium-glucose transporter 2 inhibitors

UR - https://www.scopus.com/pages/publications/85097938907

UR - https://www.scopus.com/pages/publications/85097938907#tab=citedBy

U2 - 10.1161/CIRCULATIONAHA.120.051992

DO - 10.1161/CIRCULATIONAHA.120.051992

M3 - Article

C2 - 33186508

AN - SCOPUS:85097938907

SN - 0009-7322

VL - 143

SP - 510

EP - 512

JO - Circulation

JF - Circulation

IS - 5

ER -

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this